Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.
Eileen M. Farrelly, MPH
Advertisement
Articles by Eileen M. Farrelly, MPH
Advertisement
Latest Updated Articles
- Cost of Care for Malignant and Benign Renal Masses
Published: August 12th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
How Medicaid Reforms Could Deepen State Coverage Gaps
3
Survey Reveals Clinician Confidence Around Using AI in PA Process
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
